ReviewMolecular neurobiology2025
Membrane Trafficking in Psychiatric Disorders: Bridging Cellular Dysfunction and Mental Health-A Narrative Review.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroplasticity mechanisms of NDBIs in autism: a review from brain connectivity to behavioral improvement.European journal of medical research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membrane trafficking is a fundamental cellular process responsible for transporting proteins and lipids within and between cells, essential for maintaining cellular homeostasis and supporting proper neuronal function. This narrative review examines the role of membrane trafficking in psychiatric disorders, focusing on autism spectrum disorder (ASD) and major depressive disorder (MDD), and discusses its potential as a target for pharmacological interventions. Emerging evidence shows that dysregulation of membrane trafficking is implicated in these conditions. In neurons, this process is central to synaptic transmission, neurotransmitter release, and receptor recycling, supporting neurodevelopment and brain plasticity. Disruptions can lead to altered synaptic connectivity, impaired neuroplasticity, and reduced responsiveness to pharmacological treatments. Recent studies also highlight the involvement of endosomal trafficking pathways, cytoskeletal proteins, and mitochondrial transport in their pathophysiology. Understanding the molecular mechanisms that regulate membrane trafficking may provide new insights into the etiology of ASD and MDD and open avenues for novel therapeutic strategies aimed at improving intracellular communication and neuroplasticity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.